Commentary: Anaemia in inflammatory bowel disease - The most common and ignored extra intestinal manifestation

Alimentary Pharmacology and Therapeutics

Volumn 39, Issue 2, 2014, Pages 227-228

  Fiorino, G ^a   Allocca, M ^a   Danese, S ^a  

^a HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; HEMOGLOBIN; HEPCIDIN; INTERLEUKIN 6;

ANEMIA; BLEEDING; CROHN DISEASE; DISEASE ASSOCIATION; DISEASE EXACERBATION; FOLLOW UP; HUMAN; INFLAMMATORY BOWEL DISEASE; IRON DEFICIENCY ANEMIA; MALABSORPTION; NOTE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUALITY OF LIFE; RISK FACTOR; ULCERATIVE COLITIS;

ANEMIA; COLITIS, ULCERATIVE; CROHN DISEASE; FEMALE; HUMANS; MALE;

EID: 84890452446     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/apt.12578     Document Type: Note

References (8)

1. Høivik ML, Reinisch W, Cvancarova M, Moum B,; the IBSEN study group. Anaemia in inflammatory bowel disease: a population-based 10-year follow-up. Aliment Pharmacol Ther 2014; 39: 69-76.
2. Gomollon F, Gisbert JP,. Current management of iron deficiency anemia in inflammatory bowel diseases: a practical guide. Drugs 2013; 73: 1761-70.
3. McCranor BJ, Kim MJ, Cruz NM, et al,. Interleukin-6 directly impairs the erythroid development of human TF-1 erythroleukemic cells. Blood Cells Mol Dis 2013; doi: 10.1016/j.bcmd.2013.09.004 [Epub ahead of print].
4. Poggiali E, Migone De Amicis M, Motta I,. Anemia of chronic disease: a unique defect of iron recycling for many different chronic diseases. Eur J Intern Med 2013; doi: 10.1016/j.ejim.2013.07.011 [Epub ahead of print].
5. Basseri RJ, Nemeth E, Vassilaki ME, et al,. Hepcidin is a key mediator of anemia of inflammation in Crohn's disease. J Crohns Colitis 2013; 7: e286-91.
6. Bager P, Befrits R, Wikman O, et al,. High burden of iron deficiency and different types of anemia in inflammatory bowel disease outpatients in Scandinavia: a longitudinal 2-year follow-up study. Scand J Gastroenterol 2013; 48: 1286-93.
7. Ott C, Scholmerich J,. Extraintestinal manifestations and complications in IBD. Nat Rev Gastroenterol Hepatol 2013; 10: 585-95.
8. Stein J, Bager P, Befrits R, et al,. Anaemia management in patients with inflammatory bowel disease: routine practice across nine European countries. Eur J Gastroenterol Hepatol 2013; 25: 1456-63.